mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.003 |
mRNA |
PD-0325901 |
CCLE |
pan-cancer |
AAC |
0.12 |
0.004 |
mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
0.089 |
0.004 |
mRNA |
austocystin d |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.005 |
mRNA |
masitinib |
GDSC1000 |
pan-cancer |
AAC |
0.09 |
0.006 |
mRNA |
Elesclomol |
GDSC1000 |
pan-cancer |
AAC |
-0.093 |
0.006 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.008 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.008 |
mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.009 |